Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Chinese Medicine|September 1, 2020
What we already know about rhubarb: a comprehensive reviewHong Xiang, Jiaxin Zuo, Fangyue Guo, et al.
Oncology Reports|September 17, 2019
Emodin attenuates adenosine triphosphate‑induced pancreatic ductal cell injury in vitro via the inhibition of the P2X7/NLRP3 signaling pathwayQingkai Zhang, Fenglin Hu, Fangyue Guo, et al.
Frontiers in Oncology|September 16, 2021
S100 Proteins in Pancreatic Cancer: Current Knowledge and Future PerspectivesYu Wu, Qi Zhou, Fangyue Guo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 4, 2020
Macrophages in pancreatitis: Mechanisms and therapeutic potentialFenglin Hu, Ni Lou, Juying Jiao, et al.
Pancreas|November 17, 2022
Emodin Alleviates Sodium Taurocholate-Induced Pancreatic Ductal Cell Damage by Inhibiting the S100A9/VNN1 Signaling PathwayFangyue Guo, Qi Zhou, Yu Wu, et al.
The American Journal of Chinese Medicine|September 10, 2020
Traditional Chinese Medicine as Potential Therapy for COVID-19Shuang Li, Chang Liu, Fangyue Guo, et al.
American Journal of Cancer Research|December 9, 2020
IL-17 in pancreatic disease: pathogenesis and pharmacotherapyFenglin Hu, Fangyue Guo, Yutong Zhu, et al.
Cell Death Discovery|January 29, 2024
Carfilzomib relieves pancreatitis-initiated pancreatic ductal adenocarcinoma by inhibiting high-temperature requirement protein A1Fangyue Guo, Xufeng Tao, Yu Wu, et al.
Frontiers in Oncology|April 9, 2020
T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?Qi Zhou, Xufeng Tao, Shilin Xia, et al.
Frontiers in Cellular and Infection Microbiology|August 25, 2023
The crosstalk between microbiota and metabolites in AP mice: an analysis based on metagenomics and untargeted metabolomicsQi Zhou, Xufeng Tao, Fangyue Guo, et al.
Pageof 4